A new community-based pickleball program called Project Rally is helping cancer survivors improve their physical and social well-being, according to a recent pilot study led by researchers at Moffitt Cancer Center. The program, which is offered in partnership with the YMCA of the Suncoast, has shown strong results in terms of participation, enjoyment, and physical improvements.

Under the Health Care Malpractice Act, updated in 2023, minors can recant their consent before age 25 if they develop a “permanent injury” from their treatment, with the argument that their doctor should have anticipated the patient’s health outcome and subsequent regret. Allowing patients to withdraw informed consent retroactively places an extreme burden on clinicians, limits access to gender-affirming care, and acutely threatens the legal infrastructure supporting US healthcare, according to a new perspective article by Boston University School of Public Health and Cornell Law School researchers. 

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new study.

A SickKids research team has identified a critical event driving tumour growth in a type of medulloblastoma – and a way to block it.

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. 

Now, UCSF scientists think they can throw a wrench into the fabrication of a key growth-related protein, MYC, that escalates wildly in 70% of all cancers. Unlike some other targets of cancer therapies, MYC can be dangerous simply due to its abundance.